Chalfont, PA, United States of America

Amy S Espeseth

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amy S. Espeseth: Innovator in HPV Vaccine Development

Introduction

Amy S. Espeseth is a notable inventor based in Chalfont, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of vaccines. Her work focuses on innovative solutions to combat human papillomavirus (HPV), a major health concern worldwide.

Latest Patents

Amy S. Espeseth holds 1 patent related to an HPV vaccine. The patent describes a pharmaceutical composition that includes a lipid nanoparticle adjuvant and anti-human papillomavirus (HPV) components. This composition comprises HPV virus-like particles (VLPs) from various HPV types, including types 6, 11, 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 55, 56, 58, 59, 66, 68, 73, and 82. This innovative approach aims to enhance the efficacy of HPV vaccines.

Career Highlights

Amy is associated with Merck Sharp & Dohme LLC, a leading pharmaceutical company known for its commitment to research and development. Her role at the company has allowed her to contribute to groundbreaking advancements in vaccine technology.

Collaborations

Throughout her career, Amy has collaborated with esteemed colleagues, including John P. Bilello and Marian Gindy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Amy S. Espeseth is a pioneering inventor whose work in HPV vaccine development is making a significant impact in the field of medicine. Her contributions are vital in the fight against HPV and its associated health risks.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…